Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

9.120 -0.360 (-3.80%)

Delayed Quote Updated: 1:52 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 20, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday ↗

December 20, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

Atara Biotherapeutics Announces Changes to Its Board of Directors

December 19, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD

December 19, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Presents Updated Clinical Data from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 64th American Society of Hematology (ASH) Annual Meeting

December 12, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate at the Evercore ISI 5th Annual HealthCONx Conference

November 23, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate at the Stifel Healthcare Conference

November 09, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress

November 08, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Atara Biotherapeutics's Earnings: A Preview ↗

November 07, 2022

Atara Biotherapeutics (NASDAQ:ATRA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Atara...

Via Benzinga

Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 04, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Announce Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

November 01, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Presents New MRI and Updated Open-Label Extension Data from Phase 1 Study of ATA188 in Progressive Multiple Sclerosis at ECTRIMS 2022

October 26, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Moderna, Amazon, Tesla, And Other Big Gainers From Friday ↗

October 24, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

CHMP Recommends Approval of Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease

October 14, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Receive Additional Near-Term Milestone Under Updated Tab-cel Commercialization Pact ↗

September 29, 2022

Via Benzinga

Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket ↗

September 29, 2022

Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European...

Via Benzinga

Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre

September 28, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 14, 2022

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Citigroup 17th Annual Biopharma Conference

August 31, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

NASDAQ:ATRA Shareholder Notice: Investigation over Possible Securities Laws Violations by Atara Biotherapeutics, Inc. ↗

August 18, 2022

San Diego, CA -- (SBWIRE) -- 08/18/2022 -- Atara Biotherapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.